ESTUDIOS
Publication Alert: Risk of dosing errors in ART treatment: user experience of single vs multi-use follitropin alfa pens
Bemfola® Frequently Asked Questions
VERSION NO. 4 REPLACING ALL PREVIOUS VERSIONS OF BEMFOLA® FAQ DOCUMENTS
Biosimilars to recombinant human FSH medicines:
comparable efficacy and safety to the original biologic.
Fernando de Mora a,*, Bart CJM Fauser
The continuum of ovarian response leading
to BIRTH, a real world study of ART in Spain.
Marcos Ferrando, Buenaventura Coroleu, Luis Rodríguez-Tabernero, Gorka Barrenetxea, Cristina Guix, Fernando Sánchez, Julian Jenkins* and on behalf of the BIRTH study group.
Functionality of a novel follitropin alfa pen
injector: results from human factor interactions by
patients and nurses.
Evaluation of the use and handling of three different pen systems considered for in vitro fertilization treatment.
Bruno Imthurn, Enda McVeigh, Ruth Stiller, Michelle Arnold, Fiona Pringle,
Charlotte Irps & Manfred Rettenbacher
Publication Alert: Real world study of Bemfola use in Spain.
Title: The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain
Biosimilars to recombinant human FSH medicines: comparable efficacy and safety to the original biologics.
Fernando de Mora, Bart CJM Fauser.
Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses biologics.
Helen Saunders, Laura de la Fuente Bitaine, Chriss Eftekhar, Colin M. Howles, Johanna Glaser, Tina Hoja & Pablo Arriagada
Qualitative risk assessment of follicle stimulating hormone injectable products.
Douglas T Steinke , Osman H Zarroug , Raj Mathur , Helen Kendrew & Julian Jenkins
Evaluación del uso y manejo de la pluma Bemfola® en comparación con el
de la pluma Gonal-f® y la pluma Puregon® en pacientes potenciales de FIV/
donantes de ovocitos
A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF.
Risk of dosing errors in ART treatment: user experience of single- vs multi-use follitropin alfa pens.
Helen Saunders, Linda Bjärgestad Lamp, Hasan Donat, Monja Messner, Maren Reder & Helen Kendrew
Qualitative risk assessment of follicle stimulating hormone injectable products.
Douglas T Steinke , Osman H Zarroug , Raj Mathur , Helen Kendrew & Julian
Jenkins.
Comparison of pharmacokinetic and safety profiles between Bemfola and Gonal-f after subcutaneous application.
Michael Wolzt • Ghazeleh Gouya • Michael Sator.
Thomas Hemetsberger • Charlotte Irps.
Manfred Rettenbacher • Brigitta Vcelar.